Effects of the AMPAR Antagonist, Perampanel, on Cognitive Function in Rats Exposed to Neonatal Iron Overload

da Silva, José; de Souza, Lariza Oliveira; Severo, Maria Paula Arakaki; Rodrigues, Sarah Luize Camargo; Molz, Patrícia; Schonhofen, Patrícia; Herlinger, Alice Laschuk; Schröder, Nadja

doi:10.1007/s12035-024-04180-x

Mol Neurobiol

2024

DOI: 10.1007/s12035-024-04180-x

|View full text |Cite

Effects of the AMPAR Antagonist, Perampanel, on Cognitive Function in Rats Exposed to Neonatal Iron Overload

José da Silva,

Lariza Oliveira de Souza,

Maria Paula Arakaki Severo

et al.

Help me understand this report

View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 64 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Lipsky,

Witkin,

Shafique

et al. 2024

Front. Neurosci.

View full text Add to dashboard Cite

Traumatic brain injury (TBI) has reached epidemic proportions worldwide. The consequences of TBI can be severe even with repetitive mild trauma. If death and coma are avoided, the consequences of TBI in the long term typically involve dizziness, sleep disturbances, headache, seizures, cognitive impairment, focal deficits, depression, and anxiety. The severity of brain injury is a significant predictor of outcome. However, the heterogenous nature of the injury makes prognosis difficult. The present review of the literature focuses on the genetics of TBI including genome wide (GWAS) data and candidate gene associations, among them brain-derived neurotrophic factor (BDNF) with TBI and development of post-traumatic epilepsy (PTE). Molecular biomarkers of TBI are also discussed with a focus on proteins and the inflammatory protein IL1-β. The secondary medical sequela to TBI of cognitive impairment, PTE, headache and risk for neurodegenerative disorders is also discussed. This overview of TBI concludes with a review and discussion of the medical management of TBI and the medicines used for and being developed at the preclinical and clinical stages for the treatment of TBI and its host of life-debilitating symptoms.

show abstract

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Lipsky,

Witkin,

Shafique

et al. 2024

Front. Neurosci.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Effects of the AMPAR Antagonist, Perampanel, on Cognitive Function in Rats Exposed to Neonatal Iron Overload

Cited by 1 publication

References 64 publications

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Traumatic brain injury: molecular biomarkers, genetics, secondary consequences, and medical management

Contact Info

Product

Resources

About